StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the stock.
Milestone Scientific Price Performance
Shares of MLSS stock opened at $1.01 on Friday. The firm has a 50-day moving average of $1.11 and a 200-day moving average of $0.96. The company has a market cap of $78.67 million, a P/E ratio of -14.43 and a beta of 1.41. Milestone Scientific has a one year low of $0.54 and a one year high of $1.39.
Institutional Trading of Milestone Scientific
Institutional investors and hedge funds have recently made changes to their positions in the company. Y Intercept Hong Kong Ltd purchased a new stake in shares of Milestone Scientific in the third quarter valued at about $48,000. World Investment Advisors LLC purchased a new stake in shares of Milestone Scientific in the third quarter valued at about $91,000. Renaissance Technologies LLC raised its holdings in shares of Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after purchasing an additional 53,198 shares during the last quarter. Carnegie Investment Counsel grew its position in Milestone Scientific by 18.9% during the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after buying an additional 27,412 shares during the period. Finally, Geode Capital Management LLC grew its position in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares during the period. Hedge funds and other institutional investors own 5.79% of the company’s stock.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Read More
- Five stocks we like better than Milestone Scientific
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- How to Invest in the Best Canadian StocksĀ
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.